Login / Signup

For Head and Neck Cancer, It Is Still Cisplatin, But How Much, How Often, and How Tolerable? New Randomized Phase III Data For the Adjuvant Setting.

David Neil HayesJohn Patrick GleysteenDavid Louis Schwartz
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Keyphrases
  • phase iii
  • open label
  • double blind
  • clinical trial
  • placebo controlled
  • phase ii
  • early stage
  • electronic health record
  • big data
  • machine learning